2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of HCV With a Novel Mechanism of Action

Although the direct-acting antivirals revolutionized the HCV infection treatment in last decade, more efforts are need to reach the elimination of HCV in the absence of vaccine. 4-(Piperazin-1-yl)-...